tm logo
SILICON THERAPEUTICS
ABANDONED SECTION 36

on 21 Jun 2024

Last Applicant/ Owned by

PHARMAVANT 8 INC.

151 W. 42nd StreetNew York NY 10036

US

Serial Number

2187963 filed on 11th Jan 2022

SILICON THERAPEUTICS

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 10

Atomic orbitsOrbites atomiques

24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

26 . 1 . 2

EllipsesEllipses

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 16

Circles or ellipses containing other figurative elementsCercles ou ellipses contenant d'autres éléments figuratifs

26 . 5 . 1

One polygonUn polygone

26 . 5 . 13

Polygons containing representations of heavenly bodies or natural phenomenaPolygones contenant la représentation de corps célestes ou de phénomènes naturels

26 . 5 . 9

Polygons containing one or more circles or ellipsesPolygones contenant un ou plusieurs cercles ou ellipses

26 . 7 . 7

Circle or ellipses with one or more other polygonsCercles ou ellipses avec un ou plusieurs autres polygones

29 . 1 . 4

BlueBleu

29 . 1 . 8

BlackNoir

Trademark usage description

pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; pharmaceutical preparations for human use for t Read More

Classification Information


Class [005]
Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions; Anti-cancer preparations; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Anti-cancer preparations of chemical origin; Anti-cancer preparations of plant origin; Anti-cancer preparations of microbial origin; Biopharmaceuticals for the treatment of cancer; Compounds for treating cancer; Biological preparations for medical purposes; Biological preparations for the treatment of cancer; Viral vaccines; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceuticals; Chemico-pharmaceutical preparations; Antibacterial pharmaceuticals; Anti-microbial preparations; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Vaccines; Vaccine adjuvants; Pharmaceutical preparations comprising small molecules for degrading disease-causing cellular proteins for treatment in the field of oncology; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders; Biological preparations for the treatment of viral infections; Biological preparations for the treatment of inflammatory conditions; Biological preparations for the treatment of age-related degenerative diseases; Biological preparations for the treatment of microbial, fungal and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of age-related degenerative diseases and cancers; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment and prevention of viral infections; Pharmaceutical preparations for the treatment and prevention of microbial, fungal and viral infections; Pharmaceutical preparations for the treatment and prevention of inflammatory conditions; Pharmaceutical preparations for the treatment and prevention of age-related degenerative diseases; Vaccine preparations.


Classification kind code

11

Class [042]
Scientific and technological services and research and design relating thereto; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; biomedical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Pharmaceutical research and development; Product research and development; Scientific research and development; Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology.


Classification kind code

11

Class [044]
Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions.


Classification kind code

11

Mark Details


Serial Number

2187963

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 02th Apr 2024
Default Notice Sent
Submitted for opposition 22
on 12th Sep 2023
Search Recorded
Submitted for opposition 20
on 12th Sep 2023
Examiner's First Report
Submitted for opposition 223
on 12th Sep 2023
Total Provisional Refusal
Submitted for opposition 256
on 27th Mar 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 26th May 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 26th May 2022
Created
Submitted for opposition 31
on 26th May 2022
Formalized
Submitted for opposition 30
on 11th Jan 2022
Filed
Submitted for opposition 228
on 11th Jan 2022
International Registration